Sparse Uterine Closure in Cesarean Section

January 8, 2020 updated by: Kaouther Dimassi, University Tunis El Manar

Sparse Uterine Closure in Caesarean Section: Short and Mid Term Results

The existence and the characteristics of a wedge- shaped defect in the uterine incision scar were demonstrated by radiologic, ultrasonographic, endoscopic and histologic methods by various authors.

Cesarean scar defect is a deficient uterine scar or scar dehiscence following a cesarean section involving myometrial discontinuity at the site of a previous cesarean section scar. Cesarean scar defects may be associated with many clinical problems such as ectopicpregnancy at the cesarean section scar, rupture of the uterus during a subsequent pregnancy, dysmenorrhea and abnormal uterine bleeding during the non-pregnant state. These complications are likely to be associated with poor uterine scar healing following cesarean sections.

Methods concerning closure of the uterine incision need to be considered with regards to benefit and potential harm in order to offer the best available surgical care to women undergoing cesarean section.

Sur-gical suturing technique and mechanical tension affecting the surgical wound are the most important factors related to the incisional integrity.

For this reason, investigators designed this prospective clinical study to analyze the effects of two different uterine suturing techniques. their aim was to compare the sparse closure of the uterine incision to classical one layer closure regarding short , mid and long term results. In deed, they compared :

  • duration of surgery and calculated blood loss during surgery as short term results - incidence of postoperative defective healing of the uterine incision , thickness of the ultrasound imaged uterine scar as mid-term results .
  • Incomplete uterine rupture, morbidly placental adhesion during subsequent pregnancy of these patients as long-term results.

Study Overview

Detailed Description

This is a secondary analyse of a first randomised trial comparing two caesarean techniques :

  • Misgav Ladach with a one layer classic uterine closure.
  • French ambulatory Caesarean section with a sparse uterine closure . The first trial is registred under the reference number : NCT03741907. 100 patients with an indication of an elective caesarean section were included in this trial : 50 had a one layer classic uterine closure and are enrolled in groupe 1 and 50 had a sparse uterine closure and are enrolled in groupe 2 .
  • For the short term results investigators compared : duration of uterine sutures , visually estimated and calculated blood loss
  • For the mid term results investigators are shuduling for all partient an hysterosonography 6 mounths after surgery and then will compare : incidence of postoperative defective healing of the uterine incision , thickness of the ultrasound imaged uterine scar as mid-term results .
  • For the long term results investigators will interview patients 2 years after surgery in order to check for Incomplete uterine rupture, morbidly placental adhesion during subsequent pregnancy .

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sidi Daoued La Marsa
      • Tunis, Sidi Daoued La Marsa, Tunisia, 2045
        • Kaouther Dimassi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 44 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • singleton pregnancy
  • Cicatricial uterus with contraindication to vaginal delivery (uterus bi or multi-cicatricial, corporal uterine scar, intra-mural myomectomy, dystocic presentation)
  • Fetal macrosomia with a weight greater than 4Kg
  • Placenta previa

Exclusion Criteria:

  • Patients who refuse to participate in the study
  • prenatally diagnosed fetal pathology (intrauterine growth restriction, malformation, genetics disorders)
  • adherent placenta, an adnexal mass or a myoma at the lower uterine segment
  • Cesarean section in a context of medical or obstetrical emergency
  • Caesarean section with a high risk of bleeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: sparse uterine suture
women who had a french ambulatory casarean section including a sparse uterine closure
The slowly absorbed Vicryl 1 suture with a large round needle is introduced intramyometrially right above the endometrium. The suture starts in one corner and proceeds along the lower then the upper edge returning back to the incision point. Subserous layer is closed upon using the same thread in order to cover the purse suture and to complete the haemostasis while increasing the wound thickness.
Active Comparator: one layer uterine closure
women who had a misgav ladach caesarean section section, including a one layer classical uterine closure
one layer classical continious uterine closure using slowly absorbed Vicryl 1

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
uterine scar quality
Time Frame: 6 mounth after surgery
ultrasound visualization of a defect on the internal wall of the uterine scar (niche)
6 mounth after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
uterine scar thickness
Time Frame: 6 mounth after surgery
ultrasound Measured thickness of the scar in sagittal and coronal section.
6 mounth after surgery
duration of surgery
Time Frame: during the caesarean section
time spent for uterine closure
during the caesarean section
calculated blood loss
Time Frame: before and 24 hours after surgery
post delivery hematocrit -predelivery hematocrit
before and 24 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2019

Primary Completion (Actual)

December 30, 2019

Study Completion (Actual)

January 2, 2020

Study Registration Dates

First Submitted

April 23, 2019

First Submitted That Met QC Criteria

April 25, 2019

First Posted (Actual)

April 29, 2019

Study Record Updates

Last Update Posted (Actual)

January 10, 2020

Last Update Submitted That Met QC Criteria

January 8, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • sparse uterine closure

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caesarean Scar Defect

Clinical Trials on sparse uterine suture

Subscribe